Clinical investigation of medicinal products for the management of Crohn's disease

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Currently under revision - see below

Reference numberCPMP/EWP/2284/99 Rev. 1
Published24/07/2008
Effective from01/02/2009
KeywordsCrohn’s disease
DescriptionThis document provides guidance on the clinical development of new medicinal products in the treatment of Crohn’s disease. It applies to the confirmatory studies involving the drug treatment of this disease. It does not address generic drug development.


Document history

Revision 2

In progess

Draft guideline

 

Concept paper


Concept paper

Published: 01/08/2016
Deadline for comments: 31/01/2017

 

Published: 01/10/2014


Published: 14/11/2012

Revision 1 

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/02/2009–present


Published: 18/09/2008


Published: 22/02/2007


Published: 26/01/2006


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more